EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Genomic and Functional Characterization of Palmitoylation in Clear Cell Renal Cell Carcinoma

Dong Zhang, Ke Zhang iD, Minghao Deng, Jiakang Ma, Jian Zhu, Shuijie Shen iD, Jianjun Xie iD, Chao Chen iD

Human Mutation · 2025-01 · 2025 (1)

DOI: 10.1155/humu/4647115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 29.11.2025. Verfasst von Dong Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nantong Hospital of Traditional Chinese Medicine, Affiliated Traditional Chinese Medicine Hospital of Nantong University, Nant…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Lipoylation, Kidney Neoplasms, Genomics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIBIB NIH HHS, Medical and Health Research Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clear cell renal cell carcinoma (ccRCC) is a highly aggressive cancer with a poor prognosis. Palmitoylation, a posttranslational modification, plays a key role in regulating cancer progression and immune responses. However, its influence on ccRCC prognosis and immune therapy efficacy remains underexplored.

Methods

Multiple publicly available ccRCC datasets were integrated and harmonized through batch effect correction. A prognostic model based on palmitoylation‐related genes was constructed using a combination of 101 machine learning algorithms. Single‐cell RNA sequencing was employed to analyze cellular heterogeneity within the tumor microenvironment. Genomic profiling, including tumor mutational burden (TMB), copy number variation (CNV), and tumor stemness, was conducted to identify genomic differences between the high‐ and low‐risk groups. Immune infiltration levels were assessed using various algorithms to compare immune profiles across patient subgroups, while immune therapy responses were predicted using multiple prediction models. Experimental validation of ZDHHC18, a key gene in the prognostic model, was performed in ccRCC cell lines (786‐O and Caki‐1) to evaluate its impact on cell proliferation, migration, and invasion.

Results

The palmitoylation‐related prognostic model effectively stratified ccRCC patients into the high‐ and low‐risk groups, with distinct differences in survival outcomes. Genomic analysis demonstrated higher TMB and CNV alterations in the high‐risk group. Immune response predictions indicated that low‐risk patients were more likely to benefit from immunotherapy. Additionally, ZDHHC18 was significantly upregulated in ccRCC tumor tissues, and its knockdown notably inhibited cell proliferation, migration, and invasion.

Conclusion

Palmitoylation‐related genes, particularly ZDHHC18, serve as promising prognostic biomarkers and predictive indicators for immune therapy in ccRCC. These findings offer new insights into ccRCC biology and highlight potential therapeutic targets for improving patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellLipoylationKidney NeoplasmsGenomicsHumansPrognosisDNA Copy Number VariationsCell Line, TumorGene Expression Regulation, NeoplasticBiomarkers, TumorCell ProliferationAcyltransferasesTumor MicroenvironmentMutationCell Movement

Stichwörter der Autor:innen

ZDHHC18clear cell renal cell carcinomaimmunotherapymachine learningpalmitoylationsingle-cell RNA sequencing

Substanzen

Biomarkers, TumorAcyltransferases

Autor:innen und Institutionen

  • Department of Urology, Nantong Hospital of Traditional Chinese Medicine, Affiliated Traditional Chinese Medicine Hospital of Nantong University, Nantong, China.
  • Clinical Medical Research Center, Nantong Hospital of Traditional Chinese Medicine, Affiliated Traditional Chinese Medicine Hospital of Nantong University, Nantong, China.
  • Department of Urology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China.
  • Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
  • Department of Oncology, Nantong Hospital of Traditional Chinese Medicine, Affiliated Traditional Chinese Medicine Hospital of Nantong University, Nantong, China.
  • Department of Urology, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo, China.

ORCID-Profile: Ke Zhang, Shuijie Shen, Jianjun Xie, Chao Chen

Förderung

  • NIAID NIH HHS
  • NIBIB NIH HHS
  • Medical and Health Research Project of Zhejiang Province

Zitieren

APA

Zhang, D., Zhang, K., Deng, M., Ma, J., Zhu, J., Shen, S., Xie, J., & Chen, C. (2025). Integrated Genomic and Functional Characterization of Palmitoylation in Clear Cell Renal Cell Carcinoma. Human Mutation, 2025(1). https://doi.org/10.1155/humu/4647115

Vancouver

Zhang D, Zhang K, Deng M, Ma J, Zhu J, Shen S, et al. Integrated Genomic and Functional Characterization of Palmitoylation in Clear Cell Renal Cell Carcinoma. Human Mutation. 2025;2025(1). doi:10.1155/humu/4647115

BibTeX
@article{Zhang2025,
  author = {Zhang, Dong and Zhang, Ke and Deng, Minghao and Ma, Jiakang and Zhu, Jian and Shen, Shuijie and Xie, Jianjun and Chen, Chao},
  title = {Integrated Genomic and Functional Characterization of Palmitoylation in Clear Cell Renal Cell Carcinoma},
  journal = {Human Mutation},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/humu/4647115}
}
Kostenlos starten →